Application of quality control circle activities in preventing adverse effects of subcutaneous injection in patients with cardiovascular disease

Abstract

Objective To explore the value of quality control circle (QCC) activities in predicting the adverse effects of low-molecular-weight heparin by subcutaneous injection in patients with cardiovascular disease. Methods The clinical data of totally 300 patients with cardiovascular disease (conventional nursing group) who received low-molecular-weight heparin by subcutaneous injection before QCC activities were carried out (from October 2015toApril 2016) and another 300 patients (QCC group) receiving low-molecular-weight heparin by subcutaneous injection after QCC activities were carried out (from May 2016toNovember 2016) in Nanyang City Center Hospital were retrospectively collected. The incidence rate of adverse effects of subcutaneous injection were compared before and after QCC activities, the average length of hospital stay, total expense and the number of compliant were compared between the two groups. Results The incidence rates of adverse effects of low-molecular-weight heparin by subcutaneous injection in QCC group and conventional nursing group were 1.0% and 8.0%, respectively (χ2=17.103, P<0.001) . The average length of hospital stay and total expense were (10.5±2.1) d and (5 134.8±268.4) yuan, respectively, which both were lower than those of conventional nursing group (t=10.067, 33.563; P<0.001) . There was no compliant due to adverse effects of low-molecular-weight heparin by subcutaneous injection in QCC group, whereas there were 12 complaints in conventional nursing group (P<0.05) . Conclusions QCC activities are valuable to some extent in preventing adverse effects of low-molecular-weight heparin by subcutaneous injection. Key words: Injection, subcutaneous; Quality control circle; Department of Cardiovascular Medicine; Low-molecular-weight heparin; Adverse effect